Metformin for the Prevention of CRA Recurrence

Status Recruiting

Clinical Trial Summary

Most of the sporadic colorectal cancer (CRC )develop from colorectal adenoma (CRA), patients with CRA have a high risk of recurrence and development of metachronous CRA or CRC after removal, therefore, the investigators conducted this clinical trial to explore the chemoprevetion effect of metformin for CRA recurrence after removal.

Clinical Trial Description

Colorectal adenomas are well-known to be precancerous lesions that develop into colorectal cancers on the basis of the adenoma-carcinoma sequence. The effects of screening for colorectal adenomas and removing precancerous lesions on the prevention of colorectal cancer have been established. Because of the high recurrence rates of colorectal adenomas in patients who have undergone polypectomy, the potential chemopreventive agents that may reduce the risk of colorectal adenoma recurrence need to be investigated. Metformin is a widely used diabetes medicine. In recent years, anticancer activity of metformin has been explored. The aim of this study is to investigate the effect of metformin on the recurrence of colorectal adenomas by conducting a randomized, placebo-controlled, prospective clinical. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04885426
Study type	Interventional
Source	Shanghai Jiao Tong University School of Medicine
Contact	Jing-Yuan Fang, Professor
Phone	+8613918386561
Email	jingyuanfang@sjtu.edu.cn
Status	Recruiting
Phase	N/A
Start date	August 1, 2020
Completion date	November 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04192565` - A Prospective Investigation of the ColubrisMX ELS System	N/A
Recruiting	`NCT04516785` - Reducing Colonoscopies in Patients Without Significant Bowel Disease
Recruiting	`NCT05381792` - Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia
Withdrawn	`NCT05606081` - Predicting Risk for Post-polypectomy Colorectal Cancer	N/A
Recruiting	`NCT05576506` - Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy
Active, not recruiting	`NCT03796884` - Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer	Phase 2
Completed	`NCT05508503` - A Study on a Blood-based Dual-target Test for CRC Detection
Recruiting	`NCT02935049` - Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique	N/A
Completed	`NCT05477836` - Feasibility and Safety of MiWEndo-assisted Colonoscopy	N/A
Active, not recruiting	`NCT05754229` - Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy	N/A
Active, not recruiting	`NCT05740137` - Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy	N/A
Completed	`NCT03234725` - Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial
Completed	`NCT05913453` - Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
Recruiting	`NCT05261932` - Research on Endoscopic Precision Biopsy.
Completed	`NCT02521727` - To Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas
Completed	`NCT02226185` - Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence	Phase 2/Phase 3
Completed	`NCT00298545` - Effect of Vitamin D and Calcium on Genes in the Colon	Phase 1
Completed	`NCT03268655` - Ginger and Gut Microbiome (GINGER)	N/A
Active, not recruiting	`NCT04952129` - Optimal Selenium for Bowel Polyps (OSCAR)	Phase 1
Recruiting	`NCT04444908` - Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning